Ledipasvir-sofosbuvir and sofosbuvir plus ribavirin in patients with chronic hepatitis C and bleeding disorders

Walsh, CE; Workowski, K; Terrault, NA; Sax, PE; Cohen, A; Bowlus, CL; Kim, AY; Hyland, RH; Han, B; Wang, J; Stamm, LM; Brainard, DM; McHutchison, JG; von Drygalski, A; Rhame, F; Fried, MW; Kouides, P; Balba, G; Reddy, KR

Walsh, CE (reprint author), Mt Sinai Sch Med, New York, NY 10029 USA.

HAEMOPHILIA, 2017; 23 (2): 198

Abstract

Introduction: Chronic hepatitis C virus (HCV) infection is prevalent among patients with inherited bleeding disorders and is a leading cause of mortal......

Full Text Link